Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT

F. Karl, C. Liang, R. Böttcher-Loschinski, A. Stoll, C. Flamann, S. Richter, C. Lischer, S. Völkl, B. Jacobs, M. Böttcher, R. Jitschin, H. Bruns, T. Fischer, E. Holler, W. Rösler, T. Dandekar, A. Mackensen, D. Mougiakakos

Blood (2023) 141 (13): 1626–1639.

https://doi.org/10.1182/blood.2022017267

Published: 2023

Includes: Supplemental data

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.

Joachim Kienast, D.W. Beelen, H.J. Kolb, R. Schwerdtfeger, R. Arnold, A. Reichle, E. Holler, P. Staib, M.C. Sauerland, B. Berning, C. Schmid, M. Stelljes, W.E. Berdel, W. Hiddemann, T. Buchner

Blood (2007) 110 (11): 328.

https://doi.org/10.1182/blood.V110.11.328.328

Published: 2007

Journal Articles

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

Tapani Ruutu, G. Barosi, R. J. Benjamin, R. E. Clark, J. N. George, A. Gratwohl, E. Holler, M. Iacobelli, K. Kentouche, B. Lämmle, J. L. Moake, P. Richardson, G. Socié, Z. Zeigler, D. Niederwieser, T. Barbui

Blood (2005) 106 (11): 400.

https://doi.org/10.1182/blood.V106.11.400.400

Published: 2005

Journal Articles

Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin

G Eissner, F Kohlhuber, M Grell, M Ueffing, P Scheurich, A Hieke, G Multhoff, GW Bornkamm, E Holler

Blood (1995) 86 (11): 4184–4193.

https://doi.org/10.1182/blood.V86.11.4184.bloodjournal86114184

Published: 1995

Journal Articles

Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)

E Holler, HJ Kolb, J Mittermuller, M Kaul, G Ledderose, T Duell, B Seeber, M Schleuning, R Hintermeier-Knabe, B Ertl

Blood (1995) 86 (3): 890–899.

https://doi.org/10.1182/blood.V86.3.890.890

Published: 1995

Journal Articles

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

P Herve, M Flesch, P Tiberghien, J Wijdenes, E Racadot, P Bordigoni, E Plouvier, JL Stephan, H Bourdeau, E Holler

Blood (1992) 79 (12): 3362–3368.

https://doi.org/10.1182/blood.V79.12.3362.3362

Published: 1992

Journal Articles

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

EU Irschick, F Hladik, D Niederwieser, W Nussbaumer, E Holler, E Kaminski, C Huber

Blood (1992) 79 (6): 1622–1628.

https://doi.org/10.1182/blood.V79.6.1622.1622

Published: 1992

Journal Articles

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

HJ Kolb, J Mittermuller, C Clemm, E Holler, G Ledderose, G Brehm, M Heim, W Wilmanns

Blood (1990) 76 (12): 2462–2465.

https://doi.org/10.1182/blood.V76.12.2462.2462

Published: 1990

Journal Articles

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]

E Holler, HJ Kolb, A Moller, J Kempeni, S Liesenfeld, H Pechumer, W Lehmacher, G Ruckdeschel, B Gleixner, C Riedner

Blood (1990) 75 (4): 1011–1016.

https://doi.org/10.1182/blood.V75.4.1011.1011

Published: 1990

Journal Articles

Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation

E Holler, HJ Kolb, E Hiller, W Mraz, W Lehmacher, B Gleixner, C Seeber, U Jehn, HH Gerhartz, G Brehm

Blood (1989) 73 (7): 2018–2024.

https://doi.org/10.1182/blood.V73.7.2018.2018

Published: 1989

NARROW

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT

Allogeneic Hematopoietic Stem Cell Transplantation (Allo-SCT) Versus Conventional Postremission Therapy (PRT) for AML in First Complete Remission (CR1): A Matched Pairs Analysis Based on Data of the AML Cooperative Group (AMLCG) 1999 Trial.

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]

Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only